Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACONNYSE:ATIPOTCMKTS:UDHIOTCMKTS:VYNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACONAclarion$7.22-1.5%$7.30$6.20▼$3,499.51$4.27M1.2157,955 shs18,545 shsATIPATI Physical Therapy$1.01+1.0%$0.91$0.41▼$6.59$4.46M-0.1737,691 shs252 shsUDHIUnion Dental$0.01-24.9%$0.02$0.00▼$0.15$3.64M5.081.07 million shs460,275 shsVYNTVyant Bio$0.19+7.8%$0.19$0.14▼$1.58$1.23M1.73161,822 shs19,100 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACONAclarion-1.50%-2.96%+5.09%-64.35%-99.73%ATIPATI Physical Therapy+1.00%+1.00%+12.22%-16.53%-76.24%UDHIUnion Dental0.00%-24.48%-26.40%-41.53%-36.68%VYNTVyant Bio0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACONAclarion2.7249 of 5 stars3.05.00.00.02.50.01.3ATIPATI Physical TherapyN/AN/AN/AN/AN/AN/AN/AN/AUDHIUnion DentalN/AN/AN/AN/AN/AN/AN/AN/AVYNTVyant BioN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACONAclarion 2.00Hold$11,758.50162,760.11% UpsideATIPATI Physical Therapy 0.00N/AN/AN/AUDHIUnion Dental 0.00N/AN/AN/AVYNTVyant Bio 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VYNT, UDHI, ATIP, and ACON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/30/2025ACONAclarionAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeModerate Buy(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACONAclarion$50K83.75N/AN/A$51.50 per share0.14ATIPATI Physical Therapy$741.86M0.01$5.32 per share0.19($23.96) per share-0.04UDHIUnion DentalN/AN/AN/AN/AN/AN/AVYNTVyant Bio$670K1.83N/AN/A$1.69 per share0.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACONAclarion-$6.99MN/A0.00N/AN/A-12,227.10%-126.89%-106.61%8/13/2025 (Estimated)ATIPATI Physical Therapy-$69.79M-$19.42N/A∞N/A-7.79%N/A-3.87%8/4/2025 (Estimated)UDHIUnion DentalN/AN/A0.00∞N/AN/AN/AN/AN/AVYNTVyant Bio-$22.69MN/A0.00∞N/A-3,474.81%-151.82%-97.14%N/ALatest VYNT, UDHI, ATIP, and ACON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025ACONAclarion-$1,447.20-$9.32+$1,437.88-$9.32$0.02 million$0.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACONAclarionN/AN/AN/AN/AN/AATIPATI Physical TherapyN/AN/AN/AN/AN/AUDHIUnion DentalN/AN/AN/AN/AN/AVYNTVyant BioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACONAclarionN/A21.6821.68ATIPATI Physical TherapyN/A1.121.12UDHIUnion DentalN/AN/AN/AVYNTVyant Bio0.042.862.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACONAclarion7.52%ATIPATI Physical Therapy72.60%UDHIUnion DentalN/AVYNTVyant BioN/AInsider OwnershipCompanyInsider OwnershipACONAclarion0.77%ATIPATI Physical Therapy3.30%UDHIUnion DentalN/AVYNTVyant Bio9.56%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACONAclarion7580,000578,000Not OptionableATIPATI Physical Therapy5,6004.41 million4.27 millionNo DataUDHIUnion Dental24251.32 millionN/ANot OptionableVYNTVyant Bio306.33 million5.72 millionNot OptionableVYNT, UDHI, ATIP, and ACON HeadlinesRecent News About These CompaniesVyant Bio (OTCMKTS:VYNT) Trading 7.8% Higher - Still a Buy?June 20 at 2:35 AM | americanbankingnews.comBio vs non-bio washing powderAugust 7, 2024 | which.co.ukWhat is Biotechnology?August 4, 2024 | bio.orgVyant Bio files Certificate of Dissolution with State of DelawareDecember 26, 2023 | msn.comVyant Bio Inc VYNTDecember 19, 2023 | morningstar.comVyant Bio, Inc.: Vyant Bio Provides Update on Winddown ActivitiesNovember 11, 2023 | finanznachrichten.deVyant Bio expects to start liquidation payments in Q4 2024November 10, 2023 | msn.comVyant Bio Provides Update on Winddown ActivitiesNovember 10, 2023 | finance.yahoo.comVyant Bio, Inc.: Vyant Bio Announces Stockholder Approval of Plan of DissolutionNovember 1, 2023 | finanznachrichten.deVyant Bio shareholders approve plan to dissolve companyNovember 1, 2023 | msn.comVyant Bio Announces Stockholder Approval of Plan of DissolutionNovember 1, 2023 | finance.yahoo.comNamtu Airport, Namtu, Myanmar [ NMT / VYNT ]October 28, 2023 | prokerala.comLab Notes: Philadelphia health care investment firm closes two funds valued at over $500MOctober 26, 2023 | finance.yahoo.comVyant Bio, Inc.: Vyant Bio Announces Completion of StemoniX Asset SaleOctober 25, 2023 | finanznachrichten.deVyant Bio Announces Completion of StemoniX Asset SaleOctober 24, 2023 | finance.yahoo.comVyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of StockholdersOctober 19, 2023 | finance.yahoo.comVyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of StockholdersOctober 11, 2023 | finance.yahoo.comVyant Bio, Inc.: Vyant Bio Announces Adjournment of Special Meeting of StockholdersSeptember 30, 2023 | finanznachrichten.deVyant Bio Announces Adjournment of Special Meeting of StockholdersSeptember 20, 2023 | finance.yahoo.comMedicare patients took unnecessary genetic cancer tests in man’s $463M scheme, feds sayAugust 21, 2023 | yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVYNT, UDHI, ATIP, and ACON Company DescriptionsAclarion NASDAQ:ACON$7.22 -0.11 (-1.50%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$7.54 +0.32 (+4.36%) As of 06/20/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.ATI Physical Therapy NYSE:ATIP$1.01 +0.01 (+1.00%) As of 06/20/2025 10:39 AM EasternATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy to treat spine, shoulder, knee, and neck injuries or pain; work injury rehabilitation services, work conditioning and work hardening; and hand therapy, aquatic therapy, functional capacity evaluation, sports medicine, and wellness programs. It also provides ATI worksite solutions comprising injury prevention programs, work-related injury assessment services, wellness offerings, and consultations for employers; proprietary electronic medical records (EMR) integration, caseload management, and continuing education in therapy treatments; and sports medicine, including on-site sports physical therapy, clinical evaluation and diagnosis, immediate and emergency care, nutrition programs, and concussion management services. The company offers outpatient physical therapy services under the ATI brand name. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.Union Dental OTCMKTS:UDHI$0.01 0.00 (-24.87%) As of 06/18/2025Union Dental Holdings, Inc., through its subsidiaries, provides detal services in the United States. The company operates a network of dental providers, the Dental Referral, who provide dental services through the network to union members in accordance with arrangements between UDC and various labor unions. It also manages the operation of a general dental practice. The company is based in Coral Springs, Florida.Vyant Bio OTCMKTS:VYNT$0.19 +0.01 (+7.78%) As of 12/29/2023Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
